Eurand N.V. (NASDAQ:EURX) Financial and Strategic Analysis Review
Eurand N.V. (Eurand) is a pharmaceutical company engaged in developing, manufacturing and commercialization of enhanced pharmaceutical and biopharmaceutical products using the proprietary drug formulation technologies such as Bioavailability Enhancement, Controlling Drug Release, Dosage Form and Drug Targeting. The company’s lead product EUR-1008 is pancreatic enzyme replacement product (PEP) used for the treatment of Exocrine Pancreatic Insufficiency (EPI) which is approved by FDA on June 2008. The company is headquartered in Amsterdam, The Netherlands
The Eurand N.V. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Eurand N.V.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
History 6
SWOT Analysis 7
SWOT Analysis - Overview 7
Eurand N.V. - Strengths 7
Eurand N.V. - Strengths - Acquisition of SourceCF 7
Eurand N.V. - Strengths - Patents and Proprietary Technology 7
Eurand N.V. - Strengths - Strong Product Candidate-EUR-1008 7
Eurand N.V. - Strengths - Manufacturing Facilities 7
Eurand N.V. - Weaknesses 7
Eurand N.V. - Weaknesses - Limited Distribution Network 7
Eurand N.V. - Weaknesses - Dependence on Small Group of Customers 8
Eurand N.V. - Weaknesses - Pending Lawsuits 8
Eurand N.V. - Opportunities 8
Eurand N.V. - Opportunities - Product Pipeline 8
Eurand N.V. - Opportunities - Large Market for Exocrine Pancreatic Insufficiency 8
Eurand N.V. - Threats 8
Eurand N.V. - Threats - Generic Products 8
Eurand N.V. - Threats - Dependence on Sole Supplier 8
Eurand N.V. - Threats - Product Liability 8
Key Competitors 9
Key Employees 9
Key Employee Biographies 9
Locations And Subsidiaries 10
Locations And Subsidiaries - Head Office 10
Locations And Subsidiaries - Other Locations & Subsidiaries 10
Financial Ratios 11
Financial Ratios - Capital Market Ratios 11
Financial Ratios - Annual Ratios 11
Financial Ratios - Interim Ratios 12
Financial Ratios - Ratio Charts 13
Appendix 14
Methodology 14
Ratio Definitions 14
About Global Markets Direct 17
Contact Us 17
Disclaimer 17
List of Tables
Eurand N.V., Key Facts 4
Major Products and Services 5
Eurand N.V., History 6
Eurand N.V., Key Employees 9
Eurand N.V., Key Employee Biographies 9
Eurand N.V., Other Locations 10
Eurand N.V., Subsidiaries 10
Eurand N.V., Ratios based on current share price 11
Eurand N.V., Annual Ratios 11
Eurand N.V., Interim Ratios 12
Currency Codes 14
Capital Market Ratios 14
Equity Ratios 15
Profitability Ratios 15
Cost Ratios 15
Liquidity Ratios 16
Leverage Ratios 16
Efficiency Ratios 16
List of Figures
Eurand N.V., Ratio Charts 13